The Longevity Digest 04/28 - 05/04
I'm cutting through the noise in longevity and anti-aging podcasts so you don't have to.
Welcome to The Longevity Digest.
The field moves fast. Too fast for most of us to track every breakthrough, every protocol update, every researcher’s latest findings. That’s where this comes in.
I’ve curated specific shows that consistently deliver evidence-based insights you can actually use. Think less fluff, more substance. The kind of information that changes how you practice or how you live.
Got a podcast that’s been delivering gold? Send it my way. I’m always hunting for voices that push the field forward.
This Newsletter Is Sponsored By Casa de Sante.
Dr Onyx MD PhD’s Insights on this week’s episodes
Expert Insight: The Longevity Intelligence Briefing
The signal across this week’s dispatches is unmistakable: longevity medicine is converging on a systems-biology paradigm where cellular energy, inflammatory tone, and nervous system regulation are the master levers — and the most powerful interventions are those that pull all three at once.
Section I: The Mitochondria Are the Message — Cellular Energy as the Central Command of Aging
Stop asking what’s making your patients tired. Start asking why their cells are starved of oxygen. That reframe sits at the heart of three episodes this week, and it’s clinically actionable today.
On The Human Upgrade episodes featuring Brad Pitzele (Ep. 1458, published April 30), the central argument is that microcirculatory dysfunction — not deficient bloodwork — is the silent driver of chronic fatigue, brain fog, and slow recovery in aging patients. Inflamed endothelial cells swell and reduce red blood cell deformability, creating what Pitzele calls “pseudo-hypoxia”: pulse oximetry reads normal, but tissues are running on fumes. The cells shift to low-yield anaerobic metabolism, generating a pro-inflammatory loop that compounds with each passing year. His proposed intervention — Exercise With Oxygen Therapy (EWOT, delivering ~93% O₂ via reservoir during 15 minutes of moderate exercise) stacked immediately with red/near-infrared photobiomodulation — targets both sides of the cellular energy equation simultaneously: EWOT floods tissues with oxygen supply, while photobiomodulation drives cytochrome c oxidase activity and nitric oxide–mediated vasodilation to amplify mitochondrial uptake.
Meanwhile, at the frontier of regenerative science, Daniel Ives PhD appeared on Health Longevity Secrets (April 28) to describe what may be the decade’s most consequential longevity finding: AI-guided, single-cell aging clocks at Shift Bioscience identified roughly 150 rejuvenating and 40 pro-aging genes, with approximately 10 single genes that outperform the Yamanaka factors (OSK/OSKM) in epigenetic age reversal velocity — without triggering pluripotency. The practical near-term targets emerging from this work are fibrosis (via inhibiting a widely expressed pro-aging gene) and age-related hearing loss (via localized viral delivery of a rejuvenation gene to the inner ear). The strategic takeaway for clinicians: begin incorporating validated epigenetic aging clocks as exploratory endpoints in your trials now, before these therapeutics arrive. Meanwhile, the mitochondria remain a meaningful regulatory dial — bezafibrate slows epigenetic clock rate, CCCP accelerates it — even if they are not the primary driver of aging Ives’ team originally hypothesized.
Clinical Implication: Arterial stiffness (pulse wave velocity) and VO₂ max are your proxies for mitochondrial and vascular age. Neither requires a bioprinting lab. Use them.
This Newsletter Is Sponsored By Casa de Sante.
For anyone on GLP-1 medications like Ozempic or Wegovy, Low FODMAP nutrition is non-negotiable. These medications can slow digestion and trigger bloating or nausea, so choosing gut-friendly products helps you stay comfortable while protecting muscle and metabolism. Physician-formulated by Dr Onyx MD PhD Certified in Obesity Management, this Low FODMAP lineup supports nutrient absorption, muscle defense, and overall digestive balance:
Premium Protein Powder (Vegan Vanilla, Whey Vanilla, or Whey Chocolate) – helps preserve lean muscle during weight loss
FODMAP Digestive Enzymes – improves absorption and reduces GI side effects
Advanced Probiotic + Prebiotic Synbiotic Formula – supports a balanced gut microbiome
Essential Vitamin & Mineral Complex – replenishes nutrients often depleted during rapid weight loss
Gentle Colon Cleanse + Probiotic Support – aids regular elimination without irritation
All formulas are low FODMAP, non-GMO, and third-party tested—the ideal foundation for GLP-1 users focused on digestive comfort, metabolic health, and muscle preservation.
Because hormones and skin health are deeply connected, Dr Onyx MD PhD science-backed skincare supports barrier repair, hydration, and inflammation balance for healthy, resilient skin—especially during menopause or while using GLP-1 medications, when collagen loss and dryness can accelerate:
HydraLift Collagen Complex – firms and smooths for youthful elasticity
Antioxidant C+E Ferulic Radiance Serum – brightens and defends against oxidative stress
Needle-Free Wrinkle Smoother – softens fine lines without irritation
Ultra Retinol 10x + Bakuchiol Serum – boosts cell turnover with gentle plant retinol
Advanced Retinol Eye Repair – targets puffiness and under-eye wrinkles
Cellular Repair Growth Factor Peptides Serum – rejuvenates and supports skin repair
Advanced Neck Lift Firming Complex – improves tone and texture along the jawline and neck
Even Tone Brightening Cream – evens discoloration for radiant, balanced skin
Dr Onyx Adegbola MD PhD
Track Smarter. Eat Better. Thrive. Download the GLP1 Support App at https://casadesante.com/pages/app-glp-1-support-by-dr-onyx-md-phd
Section II: The Inflammation Operating System — From NLRP3 to Mold, Every Trigger Has a Target
Inflammation is no longer a binary finding — it’s a programmable operating system. This week’s lineup spent considerable time exposing the underappreciated inputs driving that system, and the specific switches that reset it.
On The Human Upgrade Episode 1425 (published March 3), the conversation around precision medicine’s next frontier centers on the NLRP3 inflammasome — arguably the most upstream molecular villain in chronic inflammatory aging. Vagal nerve stimulation, operating through the cholinergic anti-inflammatory pathway (α7nAChR/JAK–STAT/NF-κB), can directly suppress NLRP3 activity; EGCG (green tea extract, 200–400 mg/day) was offered as an accessible adjunct. The episode argues persuasively that biomarkers like MMP-9, TGF-β1, homocysteine, and C4a — not just CRP or IL-6 — map the terrain of this system with precision, yet most standard panels ignore them entirely.
The Health Longevity Secrets “Homocysteine Story” episode (April 30) made the case that homocysteine is one of the most clinically overlooked risk markers in medicine: every 5 μmol/L rise associates with a ~20–30% increase in coronary disease risk and roughly 60% higher stroke risk, with equally compelling dose-dependent links to Alzheimer’s and all-cause dementia. The negative B-vitamin trial results that led most clinicians to dismiss homocysteine were largely secondary-prevention studies using cyanocobalamin in already folate-fortified populations — flawed by design. The corrective protocol is straightforward: measure fasting homocysteine, use active-form vitamins (methylfolate, methylcobalamin or hydroxycobalamin, and P5P), and target levels below 10 μmol/L.
But perhaps the most disruptive insight this week came from The Human Upgrade Episode 1444 (”Your AC Is Making You Dumber,” April 3), where Dave Asprey and the SuperStratum team outlined the mycotoxin-mold-mitochondria axis as a hidden driver of neurocognitive symptoms, endocrine disruption (ochratoxin A on thyroid function; zearalenone mimicking estrogen), and cardiometabolic dysfunction. Genetic susceptibility via HLA-DR4 variants affects approximately 28% of the population, explaining why one family member suffers profoundly while others appear unaffected. The clinical message is pointed: in patients with persistent, unexplained multisystem illness, ask about water-damaged buildings and HVAC maintenance before escalating medications.
Clinical Implication: Add a one-question environmental screen to every intake for chronic multisystem complaints: “Have you lived or worked in a building with visible mold, musty odors, or water damage?” The downstream diagnostic and therapeutic impact can be decisive.
Section III: The Nervous System as Longevity Infrastructure — Autonomy, Awe, and the Biology of Connection
The deepest insight this week isn’t molecular. It’s behavioral. Across six distinct episodes, a unified argument emerges: the autonomic nervous system is not a passive background system — it is active longevity infrastructure, and clinicians who ignore it are leaving the most scalable intervention on the table.
Dr. Dacher Keltner’s appearance on Huberman Lab (April 6) delivered one of the most underutilized prescriptions in all of medicine: the “awe walk.” An 8-week protocol — one 20–30 minute walk per week, shifting perceptual attention from small to vast (leaf → tree → treeline → horizon) — measurably increased vagal tone (HRV), reduced inflammatory markers, and lowered physical pain in older adults. For long COVID patients, brief daily awe practices showed preliminary signal for symptom improvement. The mechanism is elegant: awe downregulates default-mode self-focus, expands temporal perception, and engages parasympathetic tone simultaneously. Dr. Andrew Huberman’s episode featuring Dr. David Anderson (April 9) added mechanistic depth, revealing that social isolation upregulates tachykinin 2 signaling system-wide, driving aggression, anxiety, and fear via a pathway now being explored pharmacologically with NK3 receptor antagonists (osanetant reversed isolation phenotypes in preclinical models without sedation). The clinical translation is direct: isolation is not a social inconvenience — it is a biologically active, druggable brain state that clinicians should treat with the same seriousness as hypertension.
Dr. Paul Conti’s return to Huberman Lab (May 4) closed the loop with a psychotherapeutic framework that surprisingly mirrors the biological findings: agency and autonomic regulation are co-emergent. His “observing ego” concept — maintaining a coherent self across emotional states — is functionally identical to high HRV: a system with flexible, responsive regulation rather than rigid reactivity. Meanwhile, Peter Attia’s AMA #84 preview on The Drive (May 4) brought structural precision to prevention, advocating for a detailed three-generation family history as a tool that routinely outperforms consumer genetics for multifactorial disease risk — a reminder that the best longevity data sometimes comes from a conversation, not a lab order.
Clinical Implication: At your next visit, prescribe three things simultaneously: a weekly awe walk (20 minutes, outside, attention from small to vast), a social isolation screen using a 4-question touchpoint, and a five-minute paced breathing protocol (4-second inhale, 6–8 second exhale). The combined autonomic return-on-investment exceeds most supplements currently in your patient’s cabinet.
This weeks episodes:
1. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode advocates for precision medicine that integrates multi-omic data, autonomic modulation, and targeted therapeutics to optimize longevity. It highlights vagal nerve stimulation’s ability to downregulate the NLRP3 inflammasome, the need to individualize drugs and peptides, and the centrality of vascular tone/perfusion and mitochondrial function to healthy aging. Some claims are anecdotal and product-related; specific study details were not always provided in the discussion.
Key Takeaways
Precision medicine should move beyond one-size-fits-all epidemiology to N-of-1 care using multi-omics (genomics → transcriptomics → proteomics → metabolomics/exposome) to match the right intervention to the right person at the right time.
Vagal nerve stimulation engages the cholinergic anti-inflammatory pathway (α7nAChR/JAK–STAT/NF-κB) and can downregulate the NLRP3 inflammasome, a central driver of systemic inflammation and fibrosis; simple adjuncts like EGCG may also modulate NLRP3 activity.
Longevity pharmacology must be individualized: metformin is not universally beneficial (mitochondrial blunting/VO2 max concerns), rapamycin safety data are emerging (PEARL trial) but endpoints matter, and low-dose, pathway-targeted use of drugs and peptides (e.g., BPC-157, KPV, CJC-1295 with ipamorelin, PT-141) can have bioregulatory effects when used judiciously.
Vascular tone and perfusion are foundational to brain and sexual health; strategies include nitric oxide support, selective PDE5 inhibitor use (e.g., low-dose tadalafil in appropriate patients), and device-based approaches like acoustic shockwave therapy, which may promote neovascularization and lower MMP-9.
Actionable biomarkers beyond routine labs that inform aging biology include homocysteine, ApoB, Lp(a), TGF-β1, MMP-9, and C4a; pairing these with mitochondrial/energy-oriented interventions (IHHT, photobiomodulation, PEMF, HBOT) and exposome assessment can improve outcomes while AI can help sequence interventions efficiently.
Clinical Insight
Targeting autonomic balance and inflammatory set-points—specifically via vagal nerve stimulation to suppress NLRP3—combined with multi-omic profiling provides a practical, high-leverage way to personalize longevity care beyond traditional risk-factor management.
Actionable Takeaway
In patients with chronic inflammation or dysautonomia, add MMP-9 and homocysteine (along with ApoB, Lp(a), TGF-β1, and C4a when feasible) to baseline labs; if elevated, trial a noninvasive vagal nerve stimulation protocol to engage the cholinergic anti-inflammatory pathway and reassess biomarkers after 6–8 weeks.
2. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode explores how precision medicine leverages multi-omics, exposome assessment, and autonomic modulation to individualize care, with practical discussion of peptides, low-dose pharmaceuticals (e.g., tadalafil), and advanced biomarkers beyond standard panels. The conversation emphasizes sequencing interventions for mitochondrial and vascular health, measuring transcriptomic responses to confirm epigenetic effects, and safeguarding data as personalized platforms mature.
Key Takeaways
Precision medicine requires an N-of-1, multi-omic approach (genomics, transcriptomics, proteomics, epigenetics, metabolomics, exposomics) to match the right intervention to the right person at the right time.
Autonomic modulation, particularly vagal nerve stimulation, can downregulate inflammatory pathways (e.g., NLRP3 inflammasome via the cholinergic anti-inflammatory pathway) and may improve longevity-relevant markers; EGCG was cited as a practical adjunct.
Microdosing or low-dose use of select pharmaceuticals (e.g., tadalafil for vascular tone) and emerging peptide therapeutics (e.g., BPC-157, KPV, CJC-1295 with ipamorelin/semorelin, PT-141) can be useful for targeted outcomes but should be sequenced thoughtfully; metformin and rapamycin are not universal longevity solutions.
Beyond routine labs, clinicians should consider biomarkers that reflect inflammation and vascular health such as homocysteine, MMP-9, TGF-β1, C4a, nitric oxide-related function, and even cell membrane lipidomics; low cerebral perfusion is common and clinically meaningful.
Biohacking technologies (e.g., intermittent hypoxic–hyperoxic training, photobiomodulation, PEMF, HBOT, acoustic shockwave) can be potent when applied in the right order and tracked with objective data; data privacy and ownership matter as multi-omic and exposome assessments scale.
Clinical Insight
Shifting from population averages to multi-omic, N-of-1 care—while actively modulating the autonomic nervous system—allows physicians to directly influence and verify changes in key inflammatory and vascular pathways (e.g., NLRP3, nitric oxide biology), improving precision and efficiency of interventions.
Actionable Takeaway
For patients with chronic inflammation, dysautonomia, or low perfusion, implement daily noninvasive vagal nerve stimulation (or paced-breathing/HRV training) for 10–20 minutes and track CRP/IL-6 and symptom changes; consider adding a well-tolerated green tea extract providing 200–400 mg EGCG/day as an NLRP3-modulating adjunct, checking for drug–supplement interactions.
3. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
This episode argues that air-conditioning and water‑damaged indoor environments expose occupants to mycotoxins that impair mitochondrial function, cognition, hormones, metabolism, and sleep, with variable susceptibility driven partly by HLA‑DR genetics. The hosts outline a cost‑conscious, stepwise approach to ‘detoxing’ homes and vehicles—fix moisture/HVAC, oxidize/degrade mycotoxins and VOCs, reseed with environmental probiotics, and protect high‑risk surfaces—alongside humidity and dust control. Limitations: many claims are experiential or product‑specific and not independently detailed in the episode; clinicians should interpret promotional elements cautiously and corroborate with evidence-based resources.
Key Takeaways
Toxic mold and their mycotoxins (e.g., ochratoxin A, zearalenone) are fat‑soluble mitochondrial poisons that can drive multisystem illness—neurocognitive deficits, sleep disturbance with vivid nightmares, mood/behavior changes, endocrine disruption (thyroid, estrogen dominance), weight gain, easy bruising, recurrent infections, and chemical sensitivity.
Susceptibility varies widely; genetics (e.g., HLA‑DR4 variants) and exposure history modulate risk, so one family member may be severely affected while others appear well. Brain SPECT data (Amen Clinics) suggest mold exposure can reduce prefrontal activity and cognition but may be reversible after remediation.
Built environments—especially HVAC systems, ductwork, dust, moisture-prone areas, and vehicles—are common and underrecognized exposure sources; ingestion via mold‑prone foods (coffee, grains, peanuts) also contributes.
Effective management pairs medical care with environmental strategies: identify and fix moisture sources, control indoor humidity (~40–50%), address HVAC and duct contamination, reduce dust, and consider staged decontamination (oxidizing fog/gas to degrade mycotoxins and VOCs, reseeding with environmental probiotics, and protective coatings on high‑risk surfaces).
Porous belongings can carry residual mycotoxins between homes; moving without decontaminating contents often perpetuates illness. Vehicles (cars/RVs) can be significant sources due to mold and VOCs; targeted ‘detox’ is different from standard detailing.
Clinical Insight
In patients with persistent, unexplained multisystem symptoms (fatigue/brain fog, sleep disruption, mood/behavior changes, weight dysregulation, chemical sensitivity), assessing and treating the home/vehicle environment—especially moisture control and HVAC/dust contamination—can be decisive for recovery from mycotoxin-related illness.
Actionable Takeaway
Screen for water‑damaged building exposure in symptomatic patients and recommend a basic home assessment: measure/maintain indoor humidity at 40–50%, use HEPA air filtration and HEPA vacuuming to reduce dust, inspect/clean HVAC and ducts, and initiate validated environmental testing (e.g., dust-based mycotoxin or ERMI/HERTSMI‑2) before escalating medications.
4. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
Dave Asprey and the SuperStratum team discuss how indoor mold and residual mycotoxins can impair mitochondrial function and contribute to wide-ranging symptoms, with variable patient susceptibility. They outline practical, staged approaches for homes and vehicles—addressing moisture control, HVAC/duct hygiene, dust removal, and targeted decontamination of mycotoxins/VOCs—to complement or follow traditional remediation.
Key Takeaways
The episode centers on indoor mold and mycotoxins as underrecognized drivers of diverse symptoms (fatigue, brain fog, sleep disturbance, mood changes, endocrine disruption, weight gain) via mitochondrial dysfunction and immune dysregulation.
Susceptibility varies widely; about 28% of people may carry HLA-DR4 variants associated with heightened inflammatory responses and reduced ability to clear fat-soluble mycotoxins, which helps explain why household members can be affected differently.
Common exposure sources include water-damaged buildings, high indoor humidity, HVAC/ductwork, dust accumulation, and vehicles; ochratoxin A (OTA) and zearalenone are highlighted as clinically relevant mycotoxins with thyroid and estrogenic effects, respectively.
Post-remediation illness can persist due to residual mycotoxins and VOCs on surfaces and in contents; the discussion emphasizes whole-home strategies: fix moisture sources, maintain 40–50% indoor RH, clean/coat HVAC and ducts, HEPA vacuum dust, and consider targeted decontamination approaches.
The guests discuss a staged approach they use (fogging/‘bombing’ to oxidize mycotoxins/VOCs, followed by environmental probiotics and durable anti-microbial coatings) as a lower-cost adjunct to traditional remediation, and note cars can require similar detox protocols.
Clinical Insight
In patients with otherwise unexplained neurocognitive, endocrine, sleep, or cardiometabolic complaints—especially with a history of dampness or water damage—environmental mycotoxin exposure is a plausible, often overlooked contributor; assessing susceptibility, the built environment (not just visible mold), and residual mycotoxins after remediation can materially influence outcomes.
Actionable Takeaway
Incorporate a brief environmental history and screening into visits for chronic, multisystem complaints: ask about water damage/musty odors, humidity levels, HVAC maintenance, visible condensation, dust burden, and car exposures; advise maintaining indoor RH ~40–50%, fixing moisture intrusions, HEPA vacuuming dust, servicing/cleaning HVAC and ducts, and consider referral to qualified mold assessment/remediation when indicated.
5. Huberman Lab
Cultivating Awe & Emotional Connection in Daily Life | Dr. Dacher Keltner
Published: 2026-04-06
URL: Listen Here
Summary
This episode details the science of awe—how shifting from narrow to vast perception, engaging with nature and music, and synchronizing in groups reliably evokes awe with tangible benefits across inflammation, vagal tone, pain, and well-being. Practical protocols (e.g., awe walks) offer clinicians scalable tools to augment care, while insights on social bonding (embarrassment/teasing) and carefully supervised psychedelic-assisted therapy highlight additional pathways to strengthen connection and resilience. Note: Some findings (e.g., long COVID improvements from brief daily awe) are preliminary and require further peer-reviewed validation.
Key Takeaways
Awe is a measurable, health-relevant state linked to increased vagal tone (HRV), reduced inflammation, lower physical pain, and reported improvement in long COVID symptoms from brief daily awe practices.
Shifting perceptual “aperture” from small to vast (for example, moving from focusing on a leaf to the canopy to the sky/horizon) reliably evokes awe and can recalibrate arousal, time perception, and self-focus toward equanimity.
An 8-week, once-weekly 20–30 minute “awe walk” intervention in older adults increased awe, kindness, and vast attention in daily life and reduced bodily pain, with longer-term follow-up suggesting brain health benefits.
Group synchrony (music, sport, dance, chanting, shared rituals) rapidly fosters bonding and collective identity, consistent with the concept of collective effervescence; embarrassment and prosocial teasing within groups signal commitment to norms and strengthen cohesion.
Psychedelics (classic serotonergic agents) can induce profound awe and may aid treatment-resistant conditions (e.g., end-of-life anxiety, depression, PTSD) when used in structured, safe, culturally respectful settings; microdosing lacks strong clinical evidence.
Clinical Insight
Awe can be deliberately elicited (nature, music, horizons, group synchrony) and functions as a low-cost, low-risk adjunct that measurably improves autonomic balance (vagal tone), reduces inflammatory load and pain, and supports mental health—making it a viable element to integrate into preventive care and rehabilitation plans.
Actionable Takeaway
Prescribe a weekly 20–30 minute awe walk for 8 weeks: ask patients to slow their pace and breath (prolonged exhalations), and to move attention from small to vast (e.g., a leaf → tree → treeline → clouds/horizon). Encourage one brief daily “micro-awe” (≈60 seconds via nature, music, or vistas). Track simple outcomes (pain ratings, mood/sleep, HRV if available) and consider adding music- or nature-based sessions for reinforcement.
6. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode reviews the neurobiology of internal states governing aggression, mating, and arousal, emphasizing hypothalamic circuit logic, hormone signaling (notably estrogen pathways), and brain–body interactions. It highlights how social isolation engages conserved tachykinin mechanisms that amplify aggression and anxiety, suggesting concrete translational avenues (e.g., NK3 antagonists) while underscoring the clinical need to assess and address isolation.
Key Takeaways
Emotions are best understood as internal brain states (like arousal or motivation) that reshape input–output transformations of neural circuits; unlike reflexes, they often persist beyond the trigger and generalize across contexts.
Aggression is a heterogeneous set of behaviors supported by distinct but adjacent hypothalamic circuits (VMHvl): fear-related neurons can hierarchically suppress offensive aggression, and VMH integrates multisensory inputs while broadcasting low-dimensional ‘attack pressure’ signals widely.
Sex hormones do not map simply onto behavior: estrogen receptor–expressing neurons in male VMH are necessary for aggression, many testosterone effects are mediated via aromatization to estrogen, and in females, discrete VMH ER+ neuron subsets differentially control mating versus fighting.
Mating and aggression circuits exhibit reciprocal control: activating medial preoptic area (MPOA) ‘mating’ neurons can abruptly switch a male from fighting to courtship, whereas VMHvl ‘aggression’ neurons bias toward attack; PAG acts as a downstream ‘switchboard’ coordinating pain modulation and innate action patterns.
Social isolation robustly upregulates tachykinin signaling (e.g., tachykinin 2) across species, increasing aggression, fear, and anxiety; in mice, an NK3 receptor antagonist (osanotont) reverses isolation-induced phenotypes without sedation, highlighting a translational target for isolation-related psychopathology.
Clinical Insight
Social isolation is a potent, biologically mediated driver of negative affect and aggression—partly via tachykinin 2 signaling—with preclinical evidence that NK3 receptor antagonism can normalize isolation-induced aggression, fear, and anxiety without sedation; clinicians should treat isolation as a modifiable risk factor rather than a benign social state.
Actionable Takeaway
Routinely screen patients for social isolation (e.g., recent bereavement, living alone, limited social contact) and implement mitigation strategies—structured social engagement, therapy referrals, family/caregiver involvement, and follow-up touchpoints—especially in individuals showing increased irritability, anxiety, or aggression.
7. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode synthesizes neural circuit, hormonal, and neuropeptide mechanisms underlying aggression, mating, arousal, and pain modulation. Key themes include hypothalamic control of offensive aggression and its suppression by fear, estrogenic regulation of male aggression, sex-specific VMH circuits for mating vs fighting, and tachykinin-driven effects of social isolation that are reversible with NK3R antagonism—findings with clear translational relevance for stress-related behavioral health.
Key Takeaways
Emotions are best understood as internal brain states (like arousal, motivation, sleep) that transform how inputs map to outputs; compared to reflexes, emotion states show persistence and generalization beyond the initial trigger.
Aggression is a behavior that can arise from different internal states (e.g., anger, fear, hunger); in mice, ventromedial hypothalamus (VMHvl) circuits drive offensive, positively valenced aggression, while adjacent hypothalamic fear circuits can hierarchically suppress fighting.
Hormonal control of aggression in males depends critically on estrogen receptor–expressing VMH neurons and aromatization of testosterone to estrogen; estrogen implants can restore aggression in castrated male mice.
Sex-specific neural architecture shapes behavior: in females, distinct estrogen receptor–positive VMH subsets separately control mating and fighting, and medial preoptic area (MPOA) ‘mating’ neurons can acutely suppress ongoing aggression (antagonistic VMH–MPOA interactions).
Social isolation upregulates tachykinin signaling (Tac2/neurokinin B) across the brain to increase aggression, fear, and anxiety; an NK3 receptor antagonist (osanetant) reverses these effects in mice. The periaqueductal gray (PAG) acts as a hub for innate behaviors and supports endogenous, state-dependent analgesia (e.g., during fear/defense).
Clinical Insight
Chronic social isolation induces a Tac2/NK3R-mediated, druggable brain state that heightens aggression, fear, and anxiety—highlighting both the clinical importance of assessing isolation/bereavement and the translational potential of NK3 receptor antagonism for stress-related behavioral dysregulation.
Actionable Takeaway
Routinely screen patients experiencing prolonged social isolation or bereavement for irritability, aggression, and anxiety, and implement structured social reconnection strategies (e.g., group therapy, regular follow-ups, community engagement) to mitigate these biologically primed risk states.
8. The Human Upgrade: Biohacking for Longevity & Performance
Why Doctors Can’t Fix Women in 2026 : 1446
Published: 2026-04-09
URL: Listen Here
Summary
This episode argues that modern care under-treats women’s hormones and that personalized, bioidentical HRT—especially estradiol and progesterone delivered vaginally at systemic doses—can be a cornerstone for restoring libido, cognition, mood, sleep, gut/gallbladder function, and overall vitality. The guests emphasize treating to clinical response (not just numbers), considering genetics and neurotransmitters, and leveraging nutrition (adequate protein, cautious fiber, iodine) while using testosterone judiciously. Note: Many claims were experiential and not directly cited; sponsor content and controversial viewpoints are included.
Key Takeaways
Personalized, bioidentical hormone replacement (estradiol, progesterone, ± testosterone) is presented as foundational for many symptomatic women—even premenopausally—with dosing guided by symptoms and function rather than fixed lab ‘norms’ or low-dose patches/pills.
Systemic vaginal delivery of estradiol and progesterone is advocated as higher bioavailability than oral/topical/patch routes, aiming to suppress elevated FSH and improve cognition, sleep, mood, gut/gallbladder function, and sexual function; oral progesterone’s sedating effects may arise from liver-derived metabolites.
Testosterone can benefit women’s libido and cognition but excess transdermal/injected T may increase DHT/aromatization or disrupt the vaginal microbiome; many women may normalize T by optimizing progesterone, with optional low-dose topical T for event-based arousal.
Diet and environment meaningfully influence hormones and neurotransmitters: prioritize adequate protein (supporting dopamine/COMT), avoid excessive insoluble fiber and certain phytoestrogens, consider iodine repletion for breast/uterine health, and be mindful of high-oxalate foods (e.g., matcha/spinach) implicated in kidney stones and tissue symptoms.
Evaluate and treat holistically: use FSH and symptom clusters to detect early dysfunction, recognize genetic/epigenetic differences (e.g., COMT) in hormone clearance, consider neurotransmitter support (dopamine/norepinephrine/serotonin), and avoid focusing on thyroid alone when sex-hormone deficits drive multi-system complaints.
Clinical Insight
For women with multi-system symptoms (mood, sleep, gut, libido, cognitive), adequately dosed, bioidentical estradiol plus progesterone—preferably via systemic vaginal delivery—and personalized titration to clinical response can restore function across brain, immune, gut, and sexual domains; labs (including FSH) inform but should not replace symptom-guided care.
Actionable Takeaway
In an appropriate symptomatic woman (even <45), obtain FSH, estradiol, progesterone, total/free testosterone, SHBG, DHEA-S, and thyroid panel; if findings and history suggest ovarian under-function, initiate a trial of bioidentical estradiol + progesterone via systemic vaginal delivery and titrate every 6–8 weeks to symptom relief while reinforcing adequate protein intake and avoiding excessive insoluble fiber.
9. The Human Upgrade: Biohacking for Longevity & Performance
Superhuman Contact Lenses, Motivation Supplement Stack, Cat Scratches Cause Brain Fog, Amino Acid Shortening Lifespan, and more... : 1448
Published: 2026-04-10
URL: Listen Here
Summary
This episode highlights overlooked inputs—stealth infections, amino acid balance, sensory light processing, micronutrient status, and olfactory cues—that materially affect cognition, motivation, and autonomic tone. It offers practical steps clinicians can use now: targeted PCR testing for Bartonella, judicious lab monitoring around tyrosine, nutrient stacking to bolster motivation, and low-cost sensory strategies to reduce cognitive and stress load.
Key Takeaways
Cat scratches/bites can transmit Bartonella, a stealth infection linked to chronic brain fog, mood instability, and fatigue; standard serology often misses it—PCR testing is preferred and may require referral to a Lyme-literate clinician.
A Mendelian randomization analysis (~270,000 participants) associates higher circulating tyrosine with nearly one year shorter lifespan in men (not women), potentially via myeloperoxidase-driven formation of inflammatory meta-tyrosine; consider measuring plasma tyrosine and phenylalanine and avoiding unnecessary tyrosine supplementation, especially in men.
Tinted contact lenses (Altius) reportedly reduce chromatic aberration by 53% and improve contrast by 20–30%, potentially lowering visual processing load and enhancing performance; spectrum-filtering eyewear (e.g., TrueDark) and screen apps (Flux/Iris) are adjuncts.
A randomized, placebo-controlled crossover trial from the University of the Philippines found a 4-week stack (taurine 2 g, methylfolate 800 mcg, P5P 50 mg, methylcobalamin 1 mg) increased effort-based motivation and reduced attention lapses, plausibly via astrocytic glutathione support of prefrontal function.
A Monell Chemical Senses Center analysis indicates a 30-second deep nasal inhalation of floral scents can lower heart rate by 5–10 bpm and shift autonomic tone toward parasympathetic; lavender has the strongest RCT support, but pleasant florals broadly appear effective.
Clinical Insight
In patients with persistent neurocognitive or mood symptoms and a history of cat scratches/bites, Bartonella infection is likely underrecognized; order a Bartonella PCR (not just serology) and consider referral to a tick-borne disease–literate clinician, as antibody tests can miss intracellular, tissue-resident infections.
Actionable Takeaway
For patients (especially men) using tyrosine-containing supplements or very high-protein diets, obtain a fasting plasma tyrosine and phenylalanine panel (Quest/LabCorp) and review inflammatory markers; avoid or reduce tyrosine supplementation if levels are high or the tyrosine:phenylalanine ratio approaches/exceeds 10:1.
10. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
This episode features Jim O’Neill outlining an HHS/CDC push to overhaul U.S. food guidance and aging research while refocusing CDC on infectious diseases. Highlights include whole‑food, higher‑protein dietary guidance with forthcoming RCTs on saturated fat, large ARPA‑H investments in causal aging biomarkers and organ bioprinting, and greater openness to AI, wearables, non‑pharma therapies, and GLP‑1s. Several claims are policy announcements or opinions presented without primary citations.
Key Takeaways
The guest describes newly released federal dietary guidelines that emphasize whole and minimally processed foods, higher protein intake (1.2–1.6 g/kg/day), and allow meat and full‑fat dairy, while de-emphasizing refined grains and ultra‑processed foods; randomized controlled trials on saturated fats are being initiated.
HHS is prioritizing rigorous replication and aging science, including a reported $144M ARPA‑H initiative to identify causal biomarkers of aging and an organ bioprinting program that has printed a pediatric heart/vasculature (not yet implanted).
CDC is being refocused on infectious diseases, with examples cited of assisting to contain Ebola (DRC) and Marburg (Ethiopia), alongside a stated goal of rebuilding public trust through transparency.
There is openness to evaluating non‑pharmaceutical interventions (e.g., ozone therapy) with the same standards as drugs, and to integrating AI and wearables into care and surveillance—paired with strong patient consent and privacy protections.
Clinical and policy notes include support for GLP‑1s in obesity treatment, an ongoing review of upper vitamin D limits, and improvements to school meals aligned with the updated guidelines.
Clinical Insight
A shift toward whole‑food, higher‑protein nutrition with a more individualized view of dietary fats suggests clinicians should reassess grain‑centric, low‑fat counseling and focus on reducing ultra‑processed carbohydrates while tailoring fat and protein recommendations to each patient’s metabolic risk and goals.
Actionable Takeaway
For adult patients—especially those with metabolic syndrome risk or sarcopenia—calculate and document an individualized daily protein target of 1.2–1.6 g/kg from whole‑food sources, pair this with counseling to minimize ultra‑processed/refined carbohydrates, and reassess lipid/metabolic labs to tailor fat recommendations.
11. Huberman Lab
How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford
Published: 2026-04-13
URL: Listen Here
Summary
Dr. Crawford details a proactive, science‑based roadmap for improving female fertility and hormone health: use AMH and ovulation tracking to detect issues early, leverage high‑impact lifestyle changes and targeted supplements during the “trimester zero,” and apply appropriate medical tools without waiting for failure. She emphasizes avoiding cannabis and nicotine, practical contraception off‑ramp timing, and clarifies that egg freezing/IVF do not reduce ovarian reserve, while highlighting select promising but still investigational therapies. Note: Summary reflects the provided transcript and may omit topics discussed outside these excerpts.
Key Takeaways
Proactive fertility assessment matters: Anti-Müllerian Hormone (AMH) testing estimates ovarian reserve (not egg quality) and can guide life and treatment planning; it’s inexpensive (~$79) and useful even before trying to conceive.
Track ovulation, not just periods: A luteal phase <11 days is an early red flag for ovulatory dysfunction; avoid NSAIDs except during menses because they can block follicle rupture and ovulation.
Lifestyle and exposures strongly influence fertility and hormone health: Prioritize sleep (7–9 h), stress control, muscle building, anti-inflammatory nutrition, and toxin minimization; avoid cannabis and nicotine (both sexes), which impair gametes and increase miscarriage risk.
Evidence-supported preconception supplements: Begin a prenatal (with folate), CoQ10, omega-3 fatty acids, and vitamin D; for male partners, add L‑carnitine (± zinc/selenium). Consider low-dose melatonin (1–3 mg) for sleep/inflammation preconception, then stop in pregnancy.
Clinical nuances: Egg freezing/IVF do not deplete ovarian reserve; stop combined OCPs 3–6 months before trying to learn ovulation, remove levonorgestrel IUD ~6 months before attempting conception, and avoid Depo‑Provera if planning pregnancy within 1–2 years. Selective, emerging tools (e.g., GLP‑1s in insulin resistance/inflammation, intrauterine PRP for implantation failure) show promise; ovarian PRP and red light remain investigational.
Clinical Insight
Replace the “fail‑first” model with an early, data‑driven approach: normalize AMH screening and ovulation/luteal‑phase tracking for reproductive‑age women to surface problems sooner and tailor timely lifestyle, medical, or procedural interventions that can materially improve outcomes.
Actionable Takeaway
At routine visits for women who might want children, offer AMH testing and brief ovulation‑tracking education, and initiate a 60–90‑day preconception plan: sleep 7–9 h; avoid cannabis/nicotine and NSAIDs outside menses; start prenatal (folate), CoQ10 (200–400 mg/day), omega‑3 (1–2 g/day EPA+DHA), vitamin D per level; counsel partners to add L‑carnitine (≈2 g/day); reassess promptly if luteal phase <11 days, cycles irregular, age ≥35, or ≥2 pregnancy losses.
12. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
Acting CDC Director Jim O’Neill outlines a pivot in U.S. food policy toward whole foods and away from ultra‑processed, grain‑heavy patterns, alongside active trials reassessing saturated fats. He details federal investments in causal aging biomarkers via ARPA‑H, broader acceptance of AI and wearables (with consent) in care, a renewed CDC focus on infectious diseases, support for GLP‑1s in obesity management, and a review of vitamin D limits. Several points reflect evolving policy announcements described in the interview.
Key Takeaways
HHS/CDC leadership reports newly announced U.S. dietary guidelines that emphasize whole, minimally processed foods, reduce reliance on grains and ultra-processed foods, and affirm that meat and full‑fat dairy can fit into a healthy diet; randomized controlled trials on saturated fats are underway.
The government is prioritizing replication and rigor, including a $144M ARPA-H initiative to develop and FDA‑validate causal biomarkers of aging to enable surrogate endpoints for prevention and longevity therapies.
CDC is refocusing on infectious disease and highlights recent collaborations that contained Ebola (DRC) and Marburg (Ethiopia), while rebuilding public trust via transparency and focus.
There is openness to testing non‑pharmaceutical and biohacking innovations (e.g., ozone therapy) with the same scientific standards, and expanded use of wearables and AI for early detection and clinical decision support, with strong emphasis on privacy and informed consent.
GLP‑1 receptor agonists are supported as effective tools for obesity when paired with nutrition and fitness, vitamin D upper‑limit recommendations are under review, and school meals are viewed as a high‑leverage point for improving national nutrition.
Clinical Insight
Expect a policy shift in federal nutrition guidance—toward whole, minimally processed foods with adequate protein and without blanket avoidance of saturated fat/full‑fat dairy—which, combined with GLP‑1 use where appropriate, can reshape counseling and management of obesity and cardiometabolic disease.
Actionable Takeaway
Update nutrition counseling now: guide patients to prioritize whole foods and minimize ultra‑processed/refined grains, target 1.2–1.6 g/kg/day protein, individualize recommendations on saturated fat based on cardiometabolic risk, and routinely measure 25‑OH vitamin D with supplementation as needed under monitoring.
13. The Human Upgrade: Biohacking for Longevity & Performance
1 Cup Every Morning Helped Me Lose 100 Pounds (Drink THIS) : 1452
Published: 2026-04-19
URL: Listen Here
Summary
This episode is a first‑person narrative promoting butter/MCT coffee, intermittent fasting, and a high‑fat, low‑grain approach while labeling common nutrition beliefs as myths and de‑emphasizing exercise for fat loss. It reflects popular biohacking perspectives but provides limited primary evidence; clinicians may encounter patients adopting these strategies and should contextualize them within current guidelines and individualized risk assessment.
Key Takeaways
Host Dave Asprey attributes losing over 100 pounds to starting mornings with “butter coffee” (grass‑fed butter + MCT oil) and practicing intermittent fasting, emphasizing satiety, steady energy, and reduced cravings.
He presents nine “myths” he believes hinder weight loss: saturated fat is harmful; low‑fat diets are healthy; calories‑in/calories‑out drives weight change; frequent small meals boost metabolism; all vegetables are beneficial (citing anti‑nutrients in some); whole grains are healthy; fruit is universally healthy (warns about fructose); breakfast is essential; and exercise is the primary tool for fat loss.
Asprey advocates prioritizing saturated fats from grass‑fed animal sources and coconut oil, avoiding trans fats and processed seed/vegetable oils, minimizing grains and high‑fructose fruits, and selecting lower anti‑nutrient vegetables.
He claims mold/mycotoxins in some coffees drive jitters and poorer tolerance, recommending “clean” coffee; he also argues diet quality and fasting outweigh exercise for fat loss and warns that overtraining may elevate cortisol.
The episode is largely anecdotal and promotional, referencing his books and commercial products; specific primary research citations supporting many claims are not provided.
Clinical Insight
Patients may inquire about high‑fat morning beverages and time‑restricted eating to curb hunger and aid weight management; clinicians should individualize guidance and, if trialed, monitor cardiometabolic risk (e.g., LDL‑C/apoB, glycemia, liver enzymes) given that several assertions—especially high saturated fat intake and broad avoidance of plant foods/grains—diverge from prevailing evidence‑based guidelines.
Actionable Takeaway
When patients ask about “butter coffee” or intermittent fasting, offer a short, supervised 2–4 week trial of time‑restricted eating (e.g., 14–16 hour daily fast) focused on minimally processed foods; advise non‑caloric morning beverages in higher‑risk patients, track hunger/weight/glucose, and recheck lipids as indicated before making longer‑term changes.
14. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Jason Fung contends that contemporary obesity is driven primarily by hedonic and conditioned hunger magnified by ultra-processed foods and pervasive eating cues, not by a simple excess of calories. He outlines three rules—ditch ultra-processed foods, reintroduce fasting windows, and engineer environments—to lower hunger and make weight loss sustainable, positioning GLP‑1 medications as appetite-lowering tools to use alongside real‑food and behavior change.
Key Takeaways
Hunger has three distinct drivers—homeostatic (physical), hedonic (pleasure), and conditioned (cue-driven/social)—and the latter two dominate modern overeating.
Ultra-processed foods are engineered to maximize reward and minimize satiety (rapid absorption, texture modifiers, emulsifiers, flavor enhancers), amplifying hedonic and conditioned hunger independent of calories.
Sustained weight loss rarely results from calorie restriction alone; approaches that reduce hunger (diet quality, meal timing/fasting, environmental redesign) work better. GLP-1 receptor agonists help mainly by suppressing appetite but require concurrent habit change for durability.
Fung’s three golden rules: eliminate ultra-processed foods; include consistent fasting periods (reduce meal frequency/snacking); and redesign schedules/environments to remove eating cues and food noise.
Behavioral and mindset tools—such as extinction and counter-conditioning, eating only at a table, and reframing ultra-processed items as “not food”—can deprogram conditioned hunger and reduce cravings.
Clinical Insight
For patients with obesity, target hunger biology and conditioned cues rather than caloric math: assess and modify diet quality (real food over ultra-processed), structure meal timing (fasting windows), and reshape social/environmental triggers; consider GLP-1 agents to reduce appetite while concurrently coaching durable nutrition and behavioral skills.
Actionable Takeaway
At the next visit, screen for the three hunger types and initiate a 4‑week protocol: eliminate ultra-processed foods; eat 2–3 real‑food meals within an 8–10‑hour window with no calories between; and remove eating cues (no eating in the car/TV, keep snacks out of sight). If on a GLP‑1, pair with nutrition/behavioral coaching to build lasting habits.
15. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
This episode reframes obesity care around managing hunger biology and learned cues rather than prescribing calorie restriction. Fung explains how ultra-processed foods and ubiquitous food cues amplify hedonic and conditioned hunger, and outlines three practical rules—cut UPFs, add fasting windows, and redesign environments—to align physiology and behavior. GLP-1 medications can help by suppressing hunger, but sustained success depends on concurrent nutrition and behavioral retraining.
Key Takeaways
Overeating is primarily a hunger problem—not a calorie problem—with three contributors: homeostatic (physical), hedonic (pleasure-driven), and conditioned (cue-driven) hunger; in modern environments, conditioned and hedonic hunger dominate.
Ultra-processed foods are engineered to maximize reward (rapid absorption, intense flavors, optimized texture) while minimizing satiety, reinforcing both hedonic and conditioned hunger and driving habitual overconsumption.
Calorie restriction alone fails long term because physiology adapts and hunger intensifies; focusing on reducing hunger signals via food quality, structured fasting, and behavioral strategies is more sustainable.
GLP-1 receptor agonists reduce hunger and can enable weight loss, but durable results require concurrent learning of real-food eating patterns and environment/cue redesign to prevent relapse when medications stop.
Dr. Fung’s three golden rules: (1) eliminate ultra-processed foods; (2) establish consistent fasting windows and stop constant snacking; (3) redesign schedules and environments to reduce food cues, using counterconditioning and extinction to retrain conditioned hunger.
Clinical Insight
For sustained weight loss, clinicians should target the biology and behavior of hunger—especially conditioned and hedonic drivers—by replacing ultra-processed foods with real foods, implementing time-based fasting windows, and modifying environments/cues; pharmacologic appetite suppression (e.g., GLP-1 RAs) can be an adjunct but must be paired with nutrition and behavior change to maintain results.
Actionable Takeaway
Start a two-week intervention: advise patients to remove ultra-processed foods from home/work, eat 2–3 whole-food meals daily with adequate protein and natural fats, avoid between-meal snacks, and keep a 12–14-hour overnight fast; restrict eating to a table (not cars/TV) and replace evening snacking with unsweetened tea to extinguish conditioned cues, then reassess hunger/craving patterns at follow-up.
16. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Dr. Jason Fung reframes weight loss around hunger biology and environment, arguing that hedonic and conditioned hunger—amplified by ultra-processed foods and pervasive cues—drive overeating more than true physical hunger. Sustainable management targets appetite regulation (real food, fasting windows, environment design, behavioral techniques) and may incorporate GLP-1 therapy as a tool while patients build lasting dietary and behavioral skills.
Key Takeaways
Obesity is driven by three types of hunger—homeostatic (physical), hedonic (pleasure-driven), and conditioned (social/cue-driven)—with conditioned and hedonic hunger now dominating due to environment, marketing, and constant food cues.
Chronic calorie restriction fails long-term because appetite and hormones (e.g., insulin, GLP-1 pathways) govern intake and expenditure; GLP-1 receptor agonists work by lowering hunger but require concurrent nutrition and behavior change for durable results.
Ultra-processed foods (UPFs) are engineered to maximize reward (rapid absorption, flavor enhancers, emulsifiers/texturizers) and minimize satiety, amplifying ‘food noise,’ cravings, and overeating; additives like carrageenan/xanthan gum can worsen mouthfeel-driven intake and may irritate the gut.
Fung’s three golden rules: (1) eliminate UPFs in favor of real, nutrient-dense foods; (2) ensure an adequate fasting window and stop constant snacking; (3) redesign schedule and environment (eat at a table, avoid eating while driving/TV, manage cues) to reduce conditioned hunger.
Behavioral strategies such as counterconditioning (pairing cravings with aversive imagery) and extinction/substitution (e.g., tea instead of snacks while watching TV), plus a mindset shift to view UPFs as “not food,” help deprogram conditioned eating.
Clinical Insight
Effective obesity care centers on diagnosing and treating hunger dysregulation (hedonic and conditioned drivers) and hormonal responses to food, not prescribing simple calorie restriction; prioritize removal of ultra-processed foods, structured fasting/eating windows, and environmental cue control, using GLP-1s as adjuncts to reduce hunger while patients learn durable eating behaviors.
Actionable Takeaway
Start a 2–4 week ‘real food + fasting’ trial: remove all ultra-processed items and sweetened/‘diet’ beverages; eat 2–3 real-food meals daily emphasizing protein and natural fats; maintain a 12–16 hour overnight fast with no snacking; and restrict eating to a table—then reassess hunger, satiety, and weight at follow-up.
17. The Human Upgrade: Biohacking for Longevity & Performance
Inside Kambo: Poison, Purging, and The People Who Swear By It : 1455
Published: 2026-04-24
URL: Listen Here
Summary
This episode examines Kambo’s traditional origins, modern ceremonial use, administration, peptide-based mechanisms, safety profile, and preliminary human outcomes. It highlights practical risk-reduction (especially electrolyte management), underscores the paucity of rigorous clinical data, and discusses sustainability and training standards relevant to clinicians advising patients exploring Kambo.
Key Takeaways
Kambo (frog skin secretion from Phyllomedusa bicolor) is applied via superficial skin burns and is not a classical psychedelic; it induces a rapid, intense 20–30 minute experience marked by flushing, tachycardia, nausea/vomiting, sweating, shaking, transient facial swelling (“frog face”), and possible bowel movements or syncope.
Traditional Amazonian use centered on ‘hunting magic’ (adaptogenic effects like heightened perception and stamina); modern practice emphasizes ritual, trauma work, and broad wellness aims, with anecdotal utility reported for pain, autoimmune issues, infections, metabolic disease, and addiction.
Pharmacology involves at least 27 peptide analogs across eight families (e.g., opioid-receptor–active and vagal-acting peptides, antimicrobial peptides) producing vascular, GI, autonomic, and possible antipsychotic effects; however, rigorous human research on the full Kambo cocktail is sparse.
Safety hinges on preventing hyponatremia from overhydration (especially when stacked with low-salt ayahuasca dieta/fasting) and supervising to mitigate aspiration and falls; with careful screening, electrolyte management, and close monitoring, serious adverse events appear uncommon.
Emerging data (practice datasets, a post-session survey, and a prospective human study pending publication) suggest improvements in mood, mindfulness, happiness, pain, and fatigue after Kambo; sustainability and standardization remain challenges, spurring conservation work and attempts to characterize/synthesize peptide mixtures.
Clinical Insight
Kambo is a peptide-rich, non-psychedelic intervention with meaningful autonomic, GI, antimicrobial, and opioid-receptor effects that may yield short-term improvements in mood, mindfulness, and pain—yet its safe application in practice depends primarily on rigorous screening and proactive electrolyte management to prevent hyponatremia.
Actionable Takeaway
If a patient plans to undergo Kambo, counsel them to avoid overhydration: use salted fluids or oral electrolyte solution (e.g., add 1/4–1/2 tsp sea salt per liter of water), avoid low-salt/fasting protocols and stacking with ayahuasca within 24–48 hours, and ensure the session is supervised by a trained practitioner who monitors for syncope/aspiration.
18. The Human Upgrade: Biohacking for Longevity & Performance
How Beef Is Destroying Your Hormones – Cynthia Thurlow : 1457
Published: 2026-04-28
URL: Listen Here
Summary
This episode emphasizes that perimenopause is often a gut–metabolic–hormone triad problem, not solely an estrogen problem. The guests advocate early, individualized hormone support (especially oral micronized progesterone), comprehensive metabolic and thyroid testing, attention to histamine/mast-cell activity and environmental toxins (mold/xenoestrogens), and addressing trauma to reduce symptom burden and improve quality of life. Note: some policy statements and potency claims discussed were anecdotal on-air and warrant independent verification.
Key Takeaways
Perimenopause commonly begins in the late 30s to early 40s and is amplified by poor sleep, chronic stress, ultra-processed diets, and environmental toxicants; prioritizing sleep and stress recovery is foundational.
Gut–hormone–brain crosstalk strongly influences vasomotor symptoms, mood, and body composition; dysbiosis, insulin resistance, and histamine/mast-cell activation can mimic or worsen hot flashes and reactivity.
Individualized hormone care (e.g., oral micronized progesterone for sleep/anxiety, transdermal estradiol/testosterone when indicated) plus attention to thyroid status can restore motivation, cognition, and workout efficacy.
Evaluate non-obvious drivers such as mycotoxins/xenoestrogens (e.g., mold-derived estrogens, industrial exposures), iron deficiency from heavy bleeding, and tick-borne allergy (alpha-gal) when presentations are atypical.
High adverse childhood experiences (ACEs) and unresolved trauma accelerate ovarian aging via chronic HPA-axis activation; addressing trauma meaningfully improves midlife symptom trajectories.
Clinical Insight
Treat perimenopause as a systemic neuroendocrine–metabolic–gut condition: combine individualized hormone optimization (especially oral micronized progesterone), thyroid and metabolic evaluation, and gut/histamine management—while screening for environmental toxicants—to meaningfully improve sleep, cognition, vasomotor symptoms, and body composition.
Actionable Takeaway
For midlife women with sleep disruption, mood lability, and luteal-phase symptoms, order a targeted panel (fasting insulin, A1c, lipid panel with ApoB and Lp(a), ferritin, hs-CRP, TSH + free T4 + free T3, estradiol, progesterone, free/total testosterone) and consider a bedtime trial of low-dose oral micronized progesterone (e.g., 50 mg in the late luteal phase or nightly if cycles are irregular), while screening for histamine triggers (trial H1/H2 blockade if appropriate) and environmental mold exposure.
19. Health Longevity Secrets
AI-Powered Longevity Science — One Gene to Reverse Aging? | Daniel Ives PhD
Published: 2026-04-28
URL: Listen Here
Summary
This episode details how Shift Bioscience uses single-cell aging clocks and virtual cell models to prioritize rejuvenation targets at scale, revealing single genes that can reverse epigenetic age without pluripotency and outperform Yamanaka factors in vitro. The discussion outlines early translational directions (fibrosis via inhibitory targets and age-related hearing loss via local gene delivery), the limits of reprogramming, and realistic development pathways within biopharma as AI capabilities continue to expand.
Key Takeaways
Shift Bioscience pivoted from a mitochondria-centric hypothesis to an unbiased, machine-learning approach that combines single-cell aging clocks with virtual cell models to run ‘centuries’ of in silico experiments before wet-lab validation.
Epigenetic clocks disproved mitochondrial DNA mutation load as a primary driver of aging in the tested context; however, mitochondrial function/biogenesis does modulate clock rate (e.g., bezafibrate slows, CCCP accelerates), indicating a broader mitochondrial role.
AI-guided discovery revealed multiple single genes that rejuvenate cells without inducing pluripotency; ~190/1500 genes influenced aging, ~150 were rejuvenating, ~40 pro-aging, and about 10 outperformed Yamanaka factors (OSK/OSKM) in epigenetic age reversal velocity in vitro.
Two translational paths emerged: overexpressing a rejuvenation gene for age-related hearing loss (facilitated by local viral delivery to the inner ear) and inhibiting a widely expressed pro-aging gene to reduce fibrosis across organs.
Partial reprogramming with Yamanaka factors remains constrained by pluripotency/oncogenic risk and unknown mechanism; reprogramming also cannot correct fixed DNA mutations, cell loss, or autoimmunity—highlighting the need for complementary strategies and rigorous biopharma development.
Clinical Insight
Unbiased, AI-driven single-cell aging clocks and virtual perturbation models can identify gene-level interventions that reverse biological age without triggering pluripotency, suggesting safer, tissue-targeted rejuvenation strategies with near-term relevance to fibrotic diseases and age-related hearing loss.
Actionable Takeaway
When designing or participating in trials for age-related conditions, incorporate validated epigenetic aging clocks as exploratory endpoints to quantify biological-age modulation and to stratify/monitor patients in anticipation of forthcoming rejuvenation-targeted therapeutics.
20. Huberman Lab
Male Roles, Obligations and Options for Building a Fulfilling Life | Scott Galloway
Published: 2026-04-27
URL: Listen Here
Summary
This episode examines modern male roles and well-being, advancing a positive masculinity framework (provider–protector–procreator plus service) and concrete habits that build purpose, skills, and relationships. It highlights Big Tech’s role in compulsive use and isolation, advocates for mentorship and national service, and outlines policy levers (antitrust, algorithmic liability, age-gating) and personal behaviors clinicians can reinforce to improve mental health and social outcomes.
Key Takeaways
Galloway proposes a constructive masculinity code—provider, protector, procreator—augmented by service and the goal of creating “surplus value” (giving more than one takes).
Practical plan for struggling young men: reclaim screen time; train hard (≥3x/week); work outside the home (~30 hrs/week when feasible); engage weekly in team/service groups; and practice graded social “approaches,” embracing rejection as a skill-builder.
Big Tech and algorithmic feeds foster compulsive phone use, isolation, and polarization; policy remedies discussed include antitrust actions, algorithmic liability (Section 230 reform), and age-gating social media for minors.
Male mentorship and (ideally) national service are framed as high-yield solutions to purpose, skill development, and social cohesion—especially critical for boys lacking an involved male role model.
Societal/economic context matters: wealth transfer from young to old, higher-ed gatekeeping, and limited vocational on-ramps are linked to male underachievement and relationship/fertility headwinds; clinicians should recognize porn overuse as an under-researched, potentially demotivating behavior, while alcohol/THC can be net harmful or helpful depending on context and use patterns.
Clinical Insight
For young and midlife men, social isolation coupled with compulsive digital use (better conceptualized as an OCD-like compulsion loop than simple ‘dopamine hits’) is a potent driver of anxiety, depression, and suicidality; brief clinical screening and counseling that redirect time toward structured exercise, out-of-home work/school, service/mentorship, and graded real-world social engagement can meaningfully improve mental health and functioning.
Actionable Takeaway
In visits with adolescent and young adult males, add a 4-point screen—1) daily screen time and app limits, 2) exercise ≥3 days/week (resistance and/or endurance), 3) hours spent working or studying outside the home, 4) weekly group/service participation—then prescribe a 2–4 week trial to reallocate at least 8 hours/week from phone use to those activities and provide a mentorship or Big Brothers Big Sisters referral if a stable male role model is lacking.
21. The Second Opinion Podcast with Dr. Paul Kolodzik
EP116- Why Health Care Cost so Much- Why we are pissed off
Published: 2026-04-30
URL: Listen Here
Summary
This episode explores why U.S. healthcare is so expensive, highlighting the historical rise of employer-based insurance, hospital expansion, and—most importantly—industry consolidation that drives high facility and medication prices. The hosts contrast U.S. care with socialized systems, discuss price transparency pitfalls, cost shifting, and the downsides of episodic urgent care, urging informed consumerism and thoughtful end-of-life decision-making. Specific data points were illustrative and not accompanied by formal citations.
Key Takeaways
U.S. healthcare prices substantially exceed those in other developed countries, especially for hospital-based procedures and medications (e.g., total hip replacement around $30,000 in the U.S. vs. ~$10,000 abroad; higher prices noted for drugs like Herceptin and Eliquis).
Post–World War II employer-sponsored insurance and the Hill–Burton Act fueled rapid hospital growth and a shift from a service ethos to a revenue-driven industry.
Market consolidation created negotiating imbalances: insurers merged, hospitals consolidated in response, and most physicians became health-system employees—pressures that help drive high facility and drug costs rather than physician fees.
Price-transparency efforts exist but are difficult for patients to navigate; EOBs are not bills, cost-shifting (uncompensated care/Medicaid shortfalls) contributes to high premiums, and patients on high-deductible plans can sometimes secure lower cash prices than insured rates.
Compared with socialized systems that ration via queues, the U.S. often provides faster access and world-class complex care but at very high cost—particularly near end of life; continuity with a primary care clinician is preferable to episodic urgent-care-only use.
Clinical Insight
Hospital facility charges and prescription drug pricing—amplified by insurer and hospital consolidation—are the main cost drivers in U.S. care (not physician fees), so clinicians can meaningfully reduce patient financial burden by steering away from high-cost settings when appropriate, promoting longitudinal primary care, and addressing costs and goals of care up front.
Actionable Takeaway
Before any nonemergent test or procedure, have staff obtain and compare (1) the hospital’s cash/self-pay quote, (2) the payer’s negotiated rate via price-transparency tools, and (3) the patient’s out-of-pocket estimate; discuss options with the patient and proceed with the lowest reasonable pathway—documenting this step in your preauthorization workflow.
22. Huberman Lab
Essentials: Control Sugar Cravings & Metabolism with Science-Based Tools
Published: 2026-04-30
URL: Listen Here
Summary
This episode explains how dual neural circuits—sweet taste–driven dopamine and post-ingestive gut–brain signaling—govern sugar cravings, why fructose can heighten hunger, and how controlling glycemic dynamics reduces reinforcement. It offers practical strategies (food pairing to lower glycemic load, sour taste via lemon/lime, cautious cinnamon use, and medically supervised glucose-lowering agents) and emphasizes sleep as a key regulator of appetite and sugar metabolism. Note: the transcript contains a brief unclear segment around 24:50, but overall content remains clear.
Key Takeaways
Sugar seeking is driven by two parallel neural systems: (1) sweet taste–evoked mesolimbic dopamine that amplifies wanting, and (2) post-ingestive gut–brain signaling via neuropod cells through the vagus/nodose to the nucleus of the solitary tract, which reinforces intake independent of conscious taste.
Fructose—especially from high-fructose corn syrup—can increase hunger by disrupting hormones that normally suppress ghrelin; whole fruit contains far less fructose and is generally less problematic for appetite control.
Blunting rapid glycemic excursions (e.g., pairing sweets with fiber/fat/protein or choosing lower–glycemic-load options) diminishes dopaminergic reinforcement and subsequent cravings.
Simple tools such as lemon or lime juice with/around meals and modest cinnamon use can attenuate postprandial glucose; potent agents like berberine (and drugs such as metformin or glibenclamide) can markedly lower glucose and require medical supervision due to hypoglycemia risk.
Adequate, regular sleep modulates appetite and metabolic pathways; sleep disruption increases preference for sugary foods and dysregulates sugar metabolism.
Clinical Insight
Sugar cravings reflect hardwired taste- and post-ingestive–driven neural circuits; interventions that minimize rapid glycemic rises (and thus dampen dopaminergic drive) and limit fructose-heavy sources can meaningfully reduce craving intensity and improve appetite regulation.
Actionable Takeaway
Before a carbohydrate-rich or sweet meal, drink 1–2 tablespoons of lemon or lime juice diluted in water to blunt the postprandial glucose rise and downstream dopaminergic reinforcement, thereby reducing subsequent sugar cravings.
23. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explains how EWOT enhances oxygen delivery during exercise and why stacking it immediately with red/near‑infrared light amplifies mitochondrial oxygen use via nitric oxide signaling, addressing tissue‑level pseudo‑hypoxia rooted in endothelial and microvascular dysfunction. The discussion ties these mechanisms to energy, recovery, arterial flexibility, and potential applications in long‑COVID and chronic fatigue. No specific peer‑reviewed studies were cited; content reflects clinical experience and mechanistic reasoning.
Key Takeaways
Exercise With Oxygen Therapy (EWOT) delivers near‑pure oxygen (≈93%) during a short exercise bout (~15 minutes) using a reservoir, leveraging exercise‑induced vasodilation and pressure gradients to drive O2 deeper into tissues.
Stacking EWOT immediately followed by red/near‑infrared light (photobiomodulation) synergizes supply and demand: EWOT floods tissues with oxygen while red/IR light increases mitochondrial oxygen utilization and nitric oxide (NO) signaling.
Many chronic symptoms may reflect tissue‑level ‘pseudo‑hypoxia’: endothelial swelling and reduced red blood cell deformability impair capillary perfusion despite normal pulse oximetry, linking microcirculatory dysfunction to fatigue, pain, and aging.
Endothelial health and arterial flexibility matter for longevity; markers discussed include VO2 max (oxygen consumption capacity) and pulse wave velocity (arterial stiffness). Clinically observable NO/microcirculation proxies include morning erections or increased clitoral engorgement.
Adequate oxygenation supports cellular detox and repair; lungs play a major role in toxin elimination, and improving mitochondrial energy (e.g., via EWOT) may aid recovery in lung injury/long COVID when paired with photobiomodulation.
Clinical Insight
Addressing microcirculatory and endothelial dysfunction by pairing oxygen delivery (EWOT) with immediate photobiomodulation can overcome tissue‑level pseudo‑hypoxia, enhance mitochondrial ATP production, and improve recovery in conditions marked by low energy and inflammation.
Actionable Takeaway
For patients with fatigue, long‑COVID, or signs of microcirculatory/endothelial dysfunction, trial a supervised 15‑minute EWOT session (near‑pure O2 from a reservoir during moderate exercise) followed immediately by 10–20 minutes of red/near‑IR light over target regions (e.g., thorax/lungs or symptomatic areas); track response with functional metrics (e.g., VO2 surrogates/6MWT), blood pressure, and, where available, pulse wave velocity.
24. Health Longevity Secrets
EXPLAINER: Medicine’s Forgotten Biomarker - The Homocysteine Story Your Doctor Missed
Published: 2026-04-30
URL: Listen Here
Summary
This episode argues that homocysteine is a neglected yet clinically important biomarker with strong mechanistic and epidemiologic links to cardiovascular disease, stroke, and dementia. It contends that past negative trials were misinterpreted due to design and formulation issues, while more nuanced evidence supports stroke reduction and neuroprotection when homocysteine is lowered—particularly in those with elevated levels. Note: the transcript contains brief garbled sections, but the core claims and cited evidence are clear.
Key Takeaways
Elevated homocysteine is a biologically active, vascular toxin that damages endothelium via multiple mechanisms (oxidative and ER stress, nitric oxide inhibition via ADMA, NLRP3 inflammasome activation, impaired hydrogen sulfide signaling, and protein homocysteinylation), promoting atherosclerosis and thrombosis.
Epidemiologic data show a clear dose–response: every 5 μmol/L rise in homocysteine associates with roughly 20–30% higher coronary disease risk and ~60% higher stroke risk; similar dose–dependent links exist for Alzheimer’s disease and all-cause dementia.
Early B-vitamin trials that seemed to negate homocysteine’s importance were largely secondary-prevention studies, often used cyanocobalamin (potentially harmful in renal impairment), ran in folate-fortified populations, and were relatively short—yet pooled evidence still shows stroke reduction, especially in primary prevention (e.g., CSPPT).
In older adults with mild cognitive impairment and elevated homocysteine, high-dose B vitamins (folate, B12, B6) significantly slowed whole-brain and Alzheimer’s-vulnerable regional atrophy, with imaging and causal analyses linking benefit to homocysteine lowering.
Fasting homocysteine is an inexpensive, underused test; many experts target <10 μmol/L (ideally <8), and recommend active vitamin forms (methylfolate, methyl- or hydroxycobalamin, and pyridoxal-5-phosphate) while avoiding cyanocobalamin, particularly in chronic kidney disease.
Clinical Insight
Homocysteine is an independent, modifiable risk marker that refines cardiovascular and neurodegenerative risk stratification; measuring and lowering elevated levels—especially early and with appropriate B-vitamin forms—can reduce stroke risk and slow neurodegeneration in patients with high homocysteine.
Actionable Takeaway
Add a fasting homocysteine to routine risk assessment (e.g., in patients with cardiovascular risk, cognitive complaints, or metabolic dysfunction); if >10–12 μmol/L, check B12/folate status and initiate active-form B vitamins (methylfolate, methyl- or hydroxycobalamin, and P5P), avoiding cyanocobalamin in CKD, then recheck homocysteine in 8–12 weeks and titrate to <10 μmol/L (ideally <8).
25. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode outlines how EWOT and red/near-infrared light therapy can be mechanistically complementary: exercise-driven hyperoxia improves oxygen delivery while PBM increases mitochondrial oxygen demand and nitric oxide–mediated microvascular perfusion. The approach targets endothelial and mitochondrial dysfunction implicated in fatigue, chronic inflammation, and recovery limitations, with a practical protocol of 15 minutes of EWOT followed by immediate PBM. Few specific clinical trials were cited during the conversation; recommendations were largely mechanistic and experiential.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) delivers ~93% oxygen during 10–15 minutes of light-to-moderate exercise using a concentrator and large reservoir bag, leveraging exercise-induced increases in ventilation, heart rate, vasodilation, and pressure gradients to drive oxygen deeper into tissues than resting oxygen supplementation.
Chronic inflammation and endothelial dysfunction impair microcirculation (pseudo-hypoxia) even when pulse oximetry is normal; swollen endothelial cells and less-flexible RBCs limit capillary oxygen delivery, pushing cells toward anaerobic metabolism, ROS production, and a self-reinforcing inflammatory loop.
Red/near-infrared photobiomodulation (PBM) enhances mitochondrial function by increasing oxygen demand and releasing nitric oxide for vasodilation; stacking PBM immediately after EWOT (when circulation and tissue oxygen levels are elevated) amplifies outcomes (energy, sleep, pain, recovery).
A practical stack advocated: ~15 minutes of EWOT followed immediately by 10–20 minutes of red/NIR light (multiple red and NIR wavelengths) targeted to symptomatic areas or whole body to pair oxygen supply with mitochondrial uptake.
Potential use cases discussed include fatigue, long-COVID/lung injury, endothelial and microvascular dysfunction, ‘anaerobic’ infections (e.g., Lyme), and detox support; the episode’s claims were primarily mechanistic and experiential, with few specific trials cited.
Clinical Insight
Tissue-level hypoxia from microvascular/endothelial dysfunction can persist despite normal SpO2; combining EWOT to enhance oxygen delivery with photobiomodulation to increase mitochondrial oxygen utilization and nitric oxide–mediated perfusion may help break cycles of low energy, inflammation, and impaired recovery.
Actionable Takeaway
For appropriate patients, trial a stacked protocol: 10–15 minutes of moderate EWOT (reservoir-fed ~93% FiO2) followed immediately by 10–15 minutes of red/NIR photobiomodulation (e.g., 620–660 nm and 800–1050 nm) targeted to key regions (e.g., lungs, neck/shoulders, lower limbs), while monitoring HR/BP/SpO2 and tracking functional markers (symptoms, 6MWT/VO2 proxy, and if available pulse wave velocity). Screen for contraindications to high FiO2 and follow oxygen safety protocols.
26. The Human Upgrade: Biohacking for Longevity & Performance
Selfies Predict Cancer, Dirty Feed, Bone Vibration, and more... : 1459
Published: 2026-05-01
URL: Listen Here
Summary
This episode highlights how aligning with our evolutionary biology—through microbial-rich outdoor exposure, diverse movement patterns, passive mechanical loading for bone, and simple longitudinal phenotyping (serial facial images)—can yield measurable health and longevity benefits. It also urges heightened vigilance around raw dairy amid current H5N1 detections, advocating nuanced, risk-aware decision-making in clinical counseling.
Key Takeaways
Brief, nature-based exposure in early childhood (e.g., replacing rubber play surfaces with soil/plant material) doubled skin bacterial species diversity and increased expression of 10 immune-related genes by ~30% within one month, supporting the concept that immune systems need environmental microbial training.
Variety of exercise matters: engaging in at least three different activity types each week was associated with a 19–40% reduction in all-cause mortality independent of total exercise volume; cognitively/socially engaging sports like tennis and swimming showed strong effects, with benefits plateauing around 20 hours/week.
An AI-derived facial aging rate computed from serial photographs predicted 5-year cancer survival (hazard ratio ~2.1 per SD), outperforming CRP, suggesting facial aging captures systemic biological-aging signals relevant to prognosis.
Low-magnitude mechanical vibration (≈30–50 Hz) delivered via a wearable or platform may increase bone mineral density by ~2–5% in six months through Wnt/β-catenin–mediated mechanotransduction, offering a potential adjunct or alternative for individuals unable to perform heavy weight-bearing exercise.
With H5N1 detections in over 100 U.S. dairy herds, raw-milk consumption presents elevated infectious risk; stringent sourcing, pathogen testing, and individualized risk assessment are advised despite potential microbiome benefits.
Clinical Insight
Counsel patients that multimodal physical activity—incorporating several distinct exercise types each week—confers meaningful survival benefits independent of total training volume, and prioritize adding cognitively and socially engaging modalities rather than simply increasing time or intensity in a single activity.
Actionable Takeaway
In exercise prescriptions, add a specific ‘variety target’: have adult patients replace one habitual weekly session with a different modality (e.g., swimming, racquet sport, dance, or a varied-terrain/barefoot hike) for the next 8–12 weeks, while avoiding >~20 hours/week total training; reassess adherence, enjoyment, and functional metrics at follow-up.
27. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explores how EWOT and red/near-infrared light target complementary sides of cellular energetics: EWOT boosts oxygen delivery during exercise, while photobiomodulation increases mitochondrial oxygen use and nitric oxide signaling. By addressing endothelial/microcirculatory dysfunction and mitochondrial inefficiency—common in aging and chronic disease—the combined approach may enhance energy, recovery, and vascular health, with practical protocols feasible at home.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) uses a concentrator and large reservoir to deliver ~93% oxygen during 15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into hypoxic tissues.
Aging and chronic illness often feature microcirculatory dysfunction and endothelial swelling that block red blood cells from reaching capillaries, creating tissue-level “pseudo-hypoxia” despite normal pulse oximetry; mitochondria then shift to low-yield anaerobic metabolism with more inflammatory byproducts.
Red/near-infrared light (photobiomodulation) complements EWOT by increasing mitochondrial oxygen demand and efficiency (e.g., cytochrome c oxidase effects) and by promoting nitric oxide–mediated vasodilation, improving energy production and microvascular function.
Stacking protocol: complete a 15-minute EWOT session, then immediately apply red/near-IR light (10–15 minutes) to capitalize on elevated circulation and oxygen availability; simultaneous use is possible but less practical.
Discussed benefits include improved energy, sleep, pain, skin quality, recovery, and potential support in conditions with microvascular/mitochondrial dysfunction (e.g., Lyme, post-viral/long-COVID lungs), along with practical access to home EWOT systems and broad-spectrum red/IR devices.
Clinical Insight
Tissue hypoxia from microvascular and endothelial dysfunction can persist with normal SpO2 and underlies many chronic symptoms; combining strategies that enhance oxygen delivery (EWOT) with those that increase mitochondrial oxygen utilization and nitric oxide–driven vasodilation (red/near-IR light) may restore cellular energy and improve function in select patients.
Actionable Takeaway
For appropriately screened patients, implement a stack 3–5 times weekly: 15 minutes of EWOT at moderate exertion using a reservoir-fed concentrator (~93% O2), followed immediately by 10–15 minutes of red/near-IR photobiomodulation directed to priority regions (e.g., thorax for lung issues or large muscle groups); track response via symptoms (energy, sleep, pain) and, when available, vascular metrics (e.g., pulse wave velocity).
28. This Week in Cardiology
May 01 2026 This Week in Cardiology
Published: 2026-05-01
URL: Listen Here
Summary
This episode urges restraint against metric- and marketing-driven practice: use nuanced sequencing for HFrEF GDMT, scrutinize first-line PFA given safety concerns and modest symptomatic gains versus drugs, favor watchful waiting over early PVC ablation, and adopt conservative strategies for frail NSTEMI patients. The common thread is patient-centered, evidence-based decision-making that resists overtreatment and hype. Some findings come from conference abstracts and adverse-event databases, warranting cautious interpretation.
Key Takeaways
Time-to-quadruple therapy (TTQ) in HFrEF: In a VA cohort (~52,000), only 21% achieved quadruple therapy with a median TTQ ~197 days; Black and Hispanic patients had higher quadruple-therapy rates than White patients, while co-pays lowered uptake—authors propose TTQ as a benchmark, but Goodhart’s law cautions against targeting this metric; sequence GDMT thoughtfully and avoid inpatient beta-blocker initiation in low-output, hypotensive patients.
Avant-GARDE (NEJM): As first-line therapy for persistent AF, pulsed-field ablation (PFA; Boston Scientific system) improved a composite endpoint mainly by reducing asymptomatic >1-hour AF episodes on loop recorders; symptomatic AF and quality of life were similar to antiarrhythmic drugs (AADs), despite a disadvantaged AAD arm—concerningly, six strokes occurred in the PFA arm, yielding an estimated serious adverse event rate ~5%.
PFA safety signals: The TIFFANY analysis of MAUDE fatal reports suggests PFA-associated mortality may be roughly twice that of cryoballoon ablation, with arrhythmic events a prominent cause of death after PFA; limitations of voluntary reporting apply, but additional case series (e.g., ischemia/fatal arrhythmias after PFA) and expert commentary urge tempering PFA hype, pursuing head-to-head comparisons, and prioritizing transparent safety data.
TREAT-PVC (sham-controlled RCT): Low-level tragus stimulation (LLTS) did not outperform sham for reducing high-burden symptomatic PVCs at 6 months—both groups’ PVC burden and heart-rate-variability markers improved, implying natural history, regression to the mean, and/or autonomic effects of sham; supports watchful waiting and restraint from early PVC ablation.
NSTEMI in frail older adults: SENIOR-RITA overall showed no advantage of routine early invasive strategy; in the frailty subgroup (≥75 years), outcomes trended worse with invasiveness and procedural complications were higher—management should be individualized, with a conservative approach often preferable in frail patients.
Clinical Insight
Enthusiasm for PFA should be tempered by emerging safety and efficacy signals—until robust, head-to-head data confirm superiority and clarify risk, avoid defaulting to PFA as first-line for persistent AF, ensure rigorous anticoagulation/TEE protocols, and consider optimized AADs or established thermal approaches based on patient-specific risk.
Actionable Takeaway
In newly decompensated HFrEF with soft blood pressure and hypoperfusion, start afterload reduction (ACEi/ARB/ARNI) first and defer beta-blocker initiation/titration to the outpatient, euvolemic phase.
29. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explains how EWOT and red/near‑infrared light therapy can be combined to address mitochondrial dysfunction and microcirculatory ‘pseudo-hypoxia’ that underlie many chronic symptoms. The discussion emphasizes endothelial health, nitric oxide–mediated vasodilation, arterial stiffness (pulse wave velocity), and the lung’s role in detoxification, offering a practical sequencing strategy (EWOT, then PBM) to enhance energy, recovery, and tissue oxygenation. Limitations: the conversation is expert opinion–heavy and promotional in parts, and does not cite specific peer‑reviewed studies.
Key Takeaways
Exercise with oxygen therapy (EWOT) uses a concentrator and large reservoir (~93% O2) to deliver high oxygen flow during 10–15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into tissues.
Stacking red/near-infrared photobiomodulation (PBM) immediately after EWOT exploits elevated circulation and oxygen availability to increase mitochondrial oxygen demand and efficiency, enhancing energy production, recovery, pain relief, and potentially sleep, skin, and sexual function via nitric oxide signaling.
Endothelial health and microcirculation are central: inflammation causes endothelial swelling and reduced RBC deformability, creating ‘pseudo-hypoxia’ (normal SpO2 but poor tissue oxygenation) that shifts mitochondria to inefficient anaerobic metabolism and a pro-inflammatory ‘doom loop.’
Arterial stiffness is an aging biomarker (e.g., pulse wave velocity); exercise and PBM can increase nitric oxide, improve vasodilation, and may support arterial flexibility and downstream tissue oxygenation.
Lungs are major detox organs (~70% of toxin elimination); adequate oxygen is required for biotransformation and repair. EWOT may support recovery in post-viral/lung injury states by improving cellular oxygenation and mitochondrial energy needed for healing.
Clinical Insight
Sequenced therapy—EWOT to rapidly elevate tissue oxygen supply followed immediately by PBM to raise mitochondrial oxygen demand—can help overcome tissue-level ‘pseudo-hypoxia,’ restore aerobic metabolism, and improve microcirculatory function in patients with chronic inflammation, endothelial dysfunction, or post-illness fatigue.
Actionable Takeaway
Implement a clinic protocol: 10–15 minutes of EWOT (reservoir-fed ~93% O2) at moderate intensity (elevated HR/respiratory rate) followed within 5 minutes by 10–20 minutes of PBM (combined red ~630–680 nm and near-infrared ~800–1050 nm) targeted to symptomatic regions (e.g., thorax for lung, large muscle groups, or generalized exposure). Monitor SpO2/HR/BP, start with conservative dosing, and track outcomes (e.g., 6MWT, symptom scores, VO2 max trend, pulse wave velocity/microvascular assessments). Screen for photosensitizing meds and cardio-pulmonary contraindications.
30. The Human Upgrade: Biohacking for Longevity & Performance
This 9,000-Year-Old Ritual Cleared 15 Years Of Brain Fog : 1460
Published: 2026-05-03
URL: Listen Here
Summary
This episode argues that chronic stress physiology underlies much brain fog and promotes a 9,000-year-old ‘heat ritual’—modernized as infrared sauna and optional contrast therapy—to reset the nervous system and enhance clarity. It offers a stepwise practice (paced breathing, structured sauna use, hydration, and cold exposure) as adjunctive strategies; however, specific studies are not cited in-episode and the content includes paid product promotions, so clinicians should apply evidence-based screening and safety precautions.
Key Takeaways
The episode frames persistent brain fog as a manifestation of chronic sympathetic (stress) activation and potential toxin burden rather than a problem of willpower or motivation.
A simple paced-breathing practice (nasal inhale ~4 seconds, slow exhale 6–8 seconds for 5 minutes) can acutely downshift autonomic tone and signal safety to the nervous system.
Heat therapy—especially infrared sauna—is promoted as a long-standing ritual that can relax muscles, improve circulation (including cerebral blood flow), support recovery, and potentially aid detoxification; contrast therapy (alternating heat and cold) may further train nervous system flexibility.
Supplements (e.g., magnesium, B vitamins, nootropics) may provide symptomatic relief but are unlikely to resolve brain fog if underlying stress physiology and exposures persist; absorption may also be impaired during chronic stress.
A practical routine suggested: begin with shorter, lower-temperature infrared sauna sessions (10–15 minutes) and build to 30–45 minutes with good hydration and electrolytes; optionally add brief cold exposure (30–120 seconds) and repeat 2–4 hot–cold cycles, while breathing slowly and avoiding immediate return to screens.
Clinical Insight
Consider autonomic dysregulation as a core contributor to ‘brain fog’ and incorporate nonpharmacologic regulation strategies—paced breathing, heat therapy (with appropriate screening), and controlled contrast exposure—as adjuncts to standard evaluation for sleep, mood, metabolic, toxic, and inflammatory contributors.
Actionable Takeaway
Teach patients a paced-breathing protocol: three times daily, breathe nasally for 4 seconds in and 6–8 seconds out, continuously for 5 minutes while relaxing the shoulders and jaw; reassess symptoms and heart rate variability or perceived stress over 2–4 weeks.
31. The Peter Attia Drive
#390 ‒ AMA #84: Family health history, preventing heart disease, metabolic health, strength training efficiency, dementia risk reduction, NAD supplements, and hydration
Published: 2026-05-04
URL: Listen Here
Summary
This preview AMA outlines practical frameworks Peter Attia uses to navigate trade-offs in prevention: leveraging family history, aligning care with risk tolerance, improving ASCVD prevention, assessing metabolic health beyond weight, optimizing strength training efficiency, and scrutinizing NAD boosters and hydration practices. As a short teaser, it signals themes rather than detailed protocols, limiting specific clinical directives and citations.
Key Takeaways
A detailed, multi-generational family health history often provides more actionable risk information than genetic testing alone for common polygenic diseases (e.g., cardiovascular disease, diabetes, cancer) because of variable penetrance and complex genetic architecture.
Risk tolerance meaningfully shapes decisions about testing and treatment; clinicians should align recommendations with patient preferences and risk perceptions.
Despite available tools, prevention of atherosclerotic cardiovascular disease remains inadequate, underscoring the need for better risk identification and consistent application of preventive strategies.
Some individuals may carry excess body fat yet remain metabolically healthy, highlighting the importance of nuanced, phenotype-based assessment beyond BMI alone.
For time-constrained patients, prioritizing a minimum effective dose of strength training can deliver meaningful benefits; hydration and electrolyte products are often unnecessary outside specific demands; perspectives on NAD boosters (NR, NMN) depend on stronger future evidence.
Clinical Insight
For common, multifactorial conditions, a thorough three-generation family history—capturing diseases, age of onset, and causes of death—can outperform consumer genetic testing in guiding personalized prevention and screening.
Actionable Takeaway
At the next visit, implement a structured three-generation family history intake (parents, siblings, children; grandparents, aunts/uncles where possible) that records diagnoses, age at diagnosis, cause of death, major risk factors (smoking, obesity, hypertension), and ethnic background, and use it to tailor ASCVD, diabetes, and cancer screening/prevention plans.
32. Huberman Lab
Tools to Bolster Your Mental Health & Confidence | Dr. Paul Conti
Published: 2026-05-04
URL: Listen Here
Summary
Dr. Paul Conti outlines a practical, strengths-first framework for building mental health that combines compassionate self-inquiry with consistent, small actions. The episode emphasizes developing an observing self, limiting overreliance on external validation, converting insight into doable steps, and leveraging tools like thought redirection and positive memory priming to enhance agency and well-being.
Key Takeaways
Begin mental health work from a position of strength by identifying “what’s going right,” then apply compassionate curiosity to audit self-talk and your life narrative.
Healthy change requires a balance of reflection and action; collaboratively choosing small, specific steps (e.g., one workout, one hard conversation) builds momentum and adherence.
Cultivate an ‘observing ego’ to reduce state-dependence and maintain a coherent self across contexts; find a sweet spot between connection and protected alone time to limit overreliance on external validation/oversharing.
Link today’s stuck patterns to past conditioning or trauma; recognizing when you’re being ‘controlled’ by unexamined templates restores agency and unlocks behavior change.
Practical tools include thought redirection and meaning-finding for intrusive thoughts, externalizing thinking via writing/talking, and positive memory priming (e.g., displaying meaningful photos) to bias choices; aim for happiness as peace, contentment, and capacity for delight—not ‘happy-go-lucky’ denial.
Clinical Insight
Eliciting insight—framed with compassionate curiosity—that connects current maladaptive habits to earlier conditioning/trauma increases patient agency and readiness for change; pairing that insight with one collaboratively defined, achievable action between visits improves adherence more than introspection alone.
Actionable Takeaway
Add a 5–7 minute “What’s Going Right + Autopilot vs Choice” check-in each visit: (1) patient names two things going right, (2) identifies one reflexive, misaligned behavior (“the X to dig”), and (3) you co-create one small, specific step to complete before next visit; ask them to keep a brief self-talk log until then.
Stay connected with Dr Onyx MD PhD for clinical insights and wellness tools that bridge science and everyday care:
Instagram ✦ X (Twitter) ✦ LinkedIn ✦ Website
From Insights to Action
Knowledge without execution changes nothing. The insights above only reach their full potential when integrated into a strategic, personalized plan. That’s where two offerings come in:
Personalized Medical AI Chatbot
Healthcare complexity is overwhelming. Clinical studies, conflicting guidelines, and fragmented records leave most patients paralyzed.
Deploy your Dr Onyx MD PhD Medical AI Chatbot—a personalized architecture that synthesizes your medical history, the latest research, and your unique condition into clear, actionable insights.
It’s not a replacement for your doctors—it’s your secret weapon for making better decisions and becoming the CEO of your own care.
👉 Deploy your Medical AI Chatbot today and take control of your health narrative
Premium Longevity Program
For people who know their most valuable asset is their health.
This year-long partnership delivers clarity, accountability, and physician-led execution. Stop collecting fragmented data and start acting on a ranked, strategic plan tailored to your biology and lifestyle.
👉 Discover the Premium Longevity Program and secure your health as your ultimate investment.